Plant-Derived APIs for Pharmaceuticals
Indena: Plant-derived APIs for the pharmaceutical market
Indena is the world’s leading company in the identification, development and production of plant-derived active principles for the pharmaceutical, health-food and personal care industries. Backed by more than 90 years of botanical experience, phyto-chemical research is carried out in Indena’s own Settala Research Center, near Milan.
The pharmaceutical sector represents about 65% of Indena’s business and is focused mainly on anti-cancer drugs, produced in Indena’s Highly Potent Contract Manufacturing site in Settala (Italy) to US-FDA, ICH and EU requirements.
Other reference products include antigout and antihypertensive isolated pure products, antihaemorrhoidal, venotropic and cicatrizing-trophodermic selected active principles as well as capillarotropic, laxative, spasmolytic and antioedema standardized, purified or other characterized pharmaceutical extracts.
Indena’s decades-long global presence in the plant extraction industry is a guarantee of its in-depth knowledge and understanding of the business, market trends and legal considerations. There is constant communication and interaction between the company’s experts, who cooperate in the updating of all the main pharmacopoeias, and the major international regulatory authorities such as WHO, EMA, and ESCOP.
The company has more than 120 primary patents and has published more than 700 scientific studies.